Fagron NV Overview
Pro stress-test →Fagron is a pharmaceutical compounding company operating in Belgium that acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company focuses on optimizing and innovating pharmaceutical compounding to widen the therapeutic scope of prescribers worldwide.
Strategic Profile
Pro stress-test →Fagron is currently leading in pharmaceutical compounding and is active in 35 countries, with products and innovations sold to over 200,000 customers in over 60 countries around the world. The company intends to achieve growth by growing organically as well as by making selective acquisitions that complement and expand the existing strengths.
Competitive Landscape
Pro stress-test →Competitors include Medisca (Pharmaceuticals), Farmalabor, Pfizer Manufacturing Austria, Ace Pharmaceuticals, and Nephron Pharmaceuticals. Fagron's differentiation lies in its global network of compounding facilities, diversified product portfolio, and focus on personalized pharmaceutical solutions.
Industry Context
Fagron NV operates in Pharmaceutical Compounding & Healthcare Manufacturing.
Key facts
Founded: 1990 · Headquarters: Rotterdam, Netherlands (operational) / Nazareth, Belgium (registered) · Employees: 3,989 · Revenue: $943M-998M · Market cap: $1.9B